Clinical Trial Update: Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin for Hepatitis C Virus Infection in Phase 1 and Phase 2, status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin

Snippet

Sponsor: Beni-Suef University | Conditions: Hepatitis C Virus Infection | Phase 1, Phase 2 | Status: COMPLETED